Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Medtronic
(NY:
MDT
)
101.08
-0.34 (-0.34%)
Official Closing Price
Updated: 4:10 PM EST, Feb 11, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Medtronic
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
61
62
Next >
MEDTRONIC PLC (NYSE:MDT) is setting up nicely for a breakout.
↗
February 27, 2025
MEDTRONIC PLC (NYSE:MDT) Reveals Intriguing Technical Aspects. Indications Suggest NYSE:MDT Could Be on the Verge of a Breakout. Here's What You Need to Know.
Via
Chartmill
Medtronic Stock Gets IBD Rating Lift
↗
February 25, 2025
In a welcome move, Medtronic stock saw its Relative Strength Rating improve to 73 on Tuesday, up form 67 a day earlier.
Via
Investor's Business Daily
FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patients
↗
February 24, 2025
The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy personalization and clinic efficiency.
Via
Benzinga
2 Very Healthy High-Yield Dividend Stocks to Buy for a Safe and Growing Passive Income Stream
↗
February 24, 2025
Via
The Motley Fool
MarketBeat Week in Review – 02/17 - 02/21
February 22, 2025
Stocks were volatile this week as bad news gave investors a reason to sell; that volatility will continue next week with key retail earnings and inflation news
Via
MarketBeat
Topics
Economy
Is Medtronic Stock a Buy?
↗
February 21, 2025
The medical device maker has been a huge winner for its long-term shareholders.
Via
The Motley Fool
Why Medtronic Stock Is Sinking Today
↗
February 18, 2025
Via
The Motley Fool
Why Medtronic Just Undercut Its Buy Zone With A 5% Drop
↗
February 18, 2025
The company reported fiscal third-quarter earnings and, on at least one metric, disappointed investors.
Via
Investor's Business Daily
Medtronic’s Expansion Gains Momentum—Time for a Market Shift?
February 21, 2025
Medtronic is on track to complete a market reversal later this year as investments in technology and innovation begin to pay off.
Via
MarketBeat
The Smartest Dividend Stocks to Buy With $1,000 Right Now
↗
February 20, 2025
Via
The Motley Fool
Medtronic Logs Worst Day In Nearly 5 Years On Q3 Revenue Miss, But Retail Goes Bargain Hunting
↗
February 18, 2025
The company said its medical-surgical segment struggled with ongoing stapling market pressures and temporary shifts in U.S. distributor buying patterns.
Via
Stocktwits
Uncover the latest developments among S&P500 stocks in today's session.
↗
February 18, 2025
Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.
Via
Chartmill
Medtronic Unusual Options Activity For February 14
↗
February 14, 2025
Via
Benzinga
The Analyst Verdict: Medtronic In The Eyes Of 5 Experts
↗
February 12, 2025
Via
Benzinga
Stay informed with the top movers within the S&P500 index on Tuesday.
↗
February 18, 2025
Stay updated with the movements of the S&P500 index in the middle of the day on Tuesday. Discover which stocks are leading as top gainers and losers in today's session.
Via
Chartmill
US, Russia Begin Ukrainian Peace Talks, Intel Shares Surge: What's Driving Markets Tuesday?
↗
February 18, 2025
Major U.S. indices are little-changed in Tuesday's midday trading as investors monitor recent geopolitical developments and anticipate the release of the latest FOMC minutes on Wednesday.
Via
Benzinga
Medtronic (MDT) Q3 2025 Earnings Call Transcript
↗
February 18, 2025
MDT earnings call for the period ending December 31, 2024.
Via
The Motley Fool
Topics
Earnings
Which S&P500 stocks are gapping on Tuesday?
↗
February 18, 2025
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Tuesday. Discover the gap up and gap down stocks in the S&P500 index.
Via
Chartmill
Medtronic Q3 Earnings: Cardiovascular And Neuroscience Drive Growth, Surgical Revenue Dips, Reaffirms Annual Forecast
↗
February 18, 2025
Medtronic reported Q3 revenue of $8.29 billion, missing estimates, while EPS of $1.39 topped forecasts. The company reaffirmed its FY25 organic growth guidance.
Via
Benzinga
US Stocks Likely To Open Higher Amid Ukraine Peace Talk Hopes As Russian, American Officials Meet
↗
February 18, 2025
U.S. stock futures rose on Tuesday following a mixed close on Friday after the Presidents' Day holiday on Monday.
Via
Benzinga
Dow Dips Over 150 Points, But Records Weekly Gain: Investor Sentiment Improves, Greed Index In 'Fear' Zone
↗
February 18, 2025
Via
Benzinga
Topics
Stocks
Earnings Scheduled For February 18, 2025
↗
February 18, 2025
Via
Benzinga
Medtronic, Fluor And 3 Stocks To Watch Heading Into Tuesday
↗
February 18, 2025
Via
Benzinga
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom
↗
February 14, 2025
DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts highlighted long-term growth potential.
Via
Benzinga
9 Dividend Kings In The Next 5 Years
↗
February 13, 2025
Here are 9 stocks have at least 45 years of dividend increases, meaning it’s just a matter of time until they reach the Dividend Kings list.
Via
Talk Markets
Topics
Stocks / Equities
3 High-Yield Dividend Stocks I Can't Wait to Buy to Boost My Passive Income
↗
February 13, 2025
Via
The Motley Fool
Jim Cramer: This Health Care Stock Is A 'Winner,' Buy Bitcoin Instead Of Coinbase
↗
February 05, 2025
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying AbbVie Inc. (NYSE:ABBV), saying it's “just a gem” and a “winner.” He added, “I can't believe the stock dropped so much.”
Via
Benzinga
Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors
February 05, 2025
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
3 Top Dividend Stocks I Plan to Buy in My Retirement Account in February
↗
February 01, 2025
Via
The Motley Fool
Topics
Retirement
Neurotech Reports Announces First European Leaders Forum
January 30, 2025
SAN FRANCISCO, Calif., Jan. 30, 2025 (SEND2PRESS NEWSWIRE) -- Neurotech Reports, the longest-serving publishing and market intelligence firm covering the neuromodulation industry, announced the launch...
Via
Send2Press
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
61
62
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today